Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728689 · ClinicalTrials.gov registry record · Phase 1
Phase I Trial of an Investigational Small Pox Medication
A Phase 1 study, sponsored by SIGA Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00728689 is a Phase 1 study that has completed, run by SIGA Technologies. The registered enrollment target is 12 participants.
The verdict
NCT00728689, a Phase 1 study, has completed, sponsored by SIGA Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy volunteers.
Interventions
- DRUG ST-246 Days 1 - 3
- DRUG ST-246 Days 11 - 13
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728689
The ClinicalTrials.gov registry entry for NCT00728689 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SIGA Technologies, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ST-246 Days 1 - 3 is the first listed.
NCT00728689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00728689 about?
NCT00728689 is a clinical study titled "Phase I Trial of an Investigational Small Pox Medication". The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy volunteers.
What is the current status of trial NCT00728689?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-08. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00728689?
The interventions under investigation include: ST-246 Days 1 - 3 (DRUG), ST-246 Days 11 - 13 (DRUG).
Who is sponsoring clinical trial NCT00728689?
This trial is sponsored by SIGA Technologies, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.